3D Tissue Models
Medical Device Software Risk Management Standard | Software Expert 2018


San Diego, CA, San Diego, CA
http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901345SEMINAR?biotechsciencenews-January-2018-SEO
Course "Medical Device Software: An Incremental Approach to Risk and Quality Management" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview: 

Engineers are dedicated to making things work, so a focus on how they might fail and harm someone can seem alien.
Managing risk, however, is essential for all medical products- medical devices, including those involving software, have produced some painful examples of poor risk management with serious consequences. Experience has shown that there is a better way, that it is possible to manage risk in a changing business and technical world.
Regulatory bodies are placing increased emphasis on risk management, and technology shifts are introducing new sources of risk. Newer Lean-Agile methods are recognized by the FDA as a good way to accomplish risk management.
Techniques for risk management are well established, but require specific interpretation when applied to software. In this session, we will show a way of knitting risk management into the development process, so that it is integral to product development, not a ten ton caboose dragging the train back down the mountain.

Why you should attend:

Perhaps your engineering team is beginning its transition to an Agile approach - or perhaps you have a seasoned Agile team and you're just beginning work on FDA-regulated products. You know that risk management is required, but it's not at all clear how you should address it as you go through your backlog grooming, iterations, and end-user demonstrations. The process in ISO 14971 seems "linear" and unsuited to a highly iterative, dynamic lifecycle. How can you fit it into your approach?

Areas Covered in the Session:

•	Software has introduced (or been blamed for) some serious safety hazards
•	All medical device standards intersect on the topic of risk management
•	Risk analysis starts with the intended use statement
•	Risk information is available from multipl sources - use them!
•	Note that safety is an emergent property
•	Changes are often the biggest sources of risk
•	Don't ignore the human factors side; understanding your users is crucial to safety
•	Applying engineering risk methods to software requires us to translate some concepts
•	Though standards draw a roadmap for risk management, WE must figure out the route
•	Risks often arise when we add new features - so incremental risk management is the most effective
•	Forget the notion that "software can't hurt anyone"
•	Never conduct risk analysis by using a checklist from 14971
•	Exploding technology brings numerous chances for risk to multiply

Who will benefit:

•	Project managers
•	Regulatory specialists
•	Quality assurance specialists
•	Documentation specialists
•	Test managers
•	Software team leaders and lead developers

Agenda:

Day 1 Schedule

Lecture 1:
Software brings great capability to medical devices, but also creates hazards
Lecture 2:
Consider how the key standards lay out the roadmap for managing risk
Lecture 3:
Understand the key concepts - hazard, risk, and harm
Lecture 4:
Walk through ISO 14971 in detail - and consider IEC 80002-1 for specific software concerns

Day 2 Schedule

Lecture 1:
Fault tree analysis and FMEA complement each other for risk analysis
Lecture 2:
Risk analysis for software is different from hardware - and needs a place in the lifecycle
Lecture 3:
Story mapping helps bring risk management directly into development
Lecture 4:
An incremental approach manages both risk and quality




 Location: San Diego, CA Date:  January 18th & 19th, 2018 and Time: 9:00 AM to 6:00 PM
Venue: DoubleTree by Hilton San Diego Downtown   1646 Front St, San Diego, CA 92101, USA

 Price: 
Price: $1,295.00 (Seminar Fee for One Delegate)
Register now and save $200. (Early Bird)
Until December 10, Early Bird Price: $1,295.00 From December 11 to January 16, Regular Price: $1,495.00
Register for 5 attendees   Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees   Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry. 
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants. 
For More Information- https://www.globalcompliancepanel.com/control/sponsorship  
 
Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com   
support@globalcompliancepanel.com  
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
 Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901345SEMINAR?biotechsciencenews-January-2018-SEO

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel



Schedule of Presentations:

Thursday, January 18, 2018
Friday, January 19, 2018
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.